Addiction Science & Clinical Practice

Papers
(The H4-Index of Addiction Science & Clinical Practice is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Examining outcomes for service users accessing the Breaking Free Online computer-assisted therapy program for substance use disorders via a ‘telehealth’ approach: protocol for a two arm, parallel grou77
Is it about substituting an addiction with another? development and initial psychometric properties of the first heated tobacco products addiction questionnaire (HeaTPAQ)59
Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series51
Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals43
Patient perceptions of the use of e-cigarettes in smoking treatment programs: a qualitative analysis39
Improving alcohol and substance use screening in school-age children: translation, adaptation and psychometric evaluation of the CRAFFT tool for Lumasaaba, Uganda36
Psychometric properties of the cannabis abuse screening test (CAST) in a sample of Moroccans with cannabis use30
Virtual reality cue exposure as an add-on to smoking cessation group therapy: a randomized controlled trial29
Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial27
Problematic substance use among patients in a Swedish outpatient psychiatry setting: staff and manager perceptions of digital options for increased intervention access26
Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: findings from a NIDA clinical trials network site selection process25
Tobacco cessation among smokers under substance use treatment for alcohol and/or cannabis: study protocol and pilot study24
A Descriptive analysis of urine drug screen results in patients with opioid use disorder managed in a primary care setting22
Rationale and design of a randomized clinical trial of integrated eHealth for PrEP and medications for opioid use disorders for women in the criminal legal system. The Athena study22
Correction: Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population19
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use18
Effectiveness of a culturally tailored HIV intervention in promoting PrEP among black women who use drugs in community supervision programs in New York City: a randomized clinical trial17
Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study17
0.021129846572876